FI953002A0 - Förfarande för behandling av kronisk prostatainflammation med 17beta-N-monosubstituerade-karbamoyl-4-aza-5alfa-androst-1-en-3-oner - Google Patents

Förfarande för behandling av kronisk prostatainflammation med 17beta-N-monosubstituerade-karbamoyl-4-aza-5alfa-androst-1-en-3-oner

Info

Publication number
FI953002A0
FI953002A0 FI953002A FI953002A FI953002A0 FI 953002 A0 FI953002 A0 FI 953002A0 FI 953002 A FI953002 A FI 953002A FI 953002 A FI953002 A FI 953002A FI 953002 A0 FI953002 A0 FI 953002A0
Authority
FI
Finland
Prior art keywords
androst
aza
treatment
5alpha
17beta
Prior art date
Application number
FI953002A
Other languages
English (en)
Finnish (fi)
Other versions
FI953002A (sv
Inventor
Glenn J Gormley
Elizabeth Stoner
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI953002A publication Critical patent/FI953002A/sv
Publication of FI953002A0 publication Critical patent/FI953002A0/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI953002A 1992-12-18 1995-06-16 Förfarande för behandling av kronisk prostatainflammation med 17beta-N-monosubstituerade-karbamoyl-4-aza-5alfa-androst-1-en-3-oner FI953002A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99298592A 1992-12-18 1992-12-18
PCT/US1993/011155 WO1994014452A1 (en) 1992-12-18 1993-11-18 METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17β-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5α-ANDROST-1-EN-3-ONES

Publications (2)

Publication Number Publication Date
FI953002A FI953002A (sv) 1995-06-16
FI953002A0 true FI953002A0 (sv) 1995-06-16

Family

ID=25538974

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953002A FI953002A0 (sv) 1992-12-18 1995-06-16 Förfarande för behandling av kronisk prostatainflammation med 17beta-N-monosubstituerade-karbamoyl-4-aza-5alfa-androst-1-en-3-oner

Country Status (17)

Country Link
US (1) US5629318A (sv)
EP (1) EP0674521B1 (sv)
JP (1) JPH08504813A (sv)
AT (1) ATE203162T1 (sv)
AU (1) AU691164B2 (sv)
CA (1) CA2151239A1 (sv)
CZ (1) CZ285379B6 (sv)
DE (1) DE69330465T2 (sv)
DK (1) DK0674521T3 (sv)
ES (1) ES2158887T3 (sv)
FI (1) FI953002A0 (sv)
GR (1) GR3036241T3 (sv)
HU (1) HU220064B (sv)
NO (1) NO308829B1 (sv)
NZ (1) NZ258435A (sv)
PT (1) PT674521E (sv)
WO (1) WO1994014452A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999059583A1 (en) * 1998-05-18 1999-11-25 Merck & Co., Inc. Method for treating or preventing chronic nonbacterial prostatitis and prostatodynia
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
US7101847B2 (en) * 2002-10-11 2006-09-05 Milkhaus Laboratory, Inc. Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin
EP1663228A4 (en) * 2003-09-10 2010-10-06 Merck Sharp & Dohme USE OF 17-HETEROCYCLIC-4-AZASTEROIDIAN DERIVATIVES AS MODULATORS OF THE ANDROGEN RECEPTOR
WO2005044988A2 (en) * 2003-10-31 2005-05-19 Merck & Co., Inc. 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
US20080268463A1 (en) * 2007-03-07 2008-10-30 Children's Medical Center Corporation Methods for Prognosis and Diagnosis of Chronic Prostatitis/Pelvic Pain Syndrome and Interstitial Cystitis
RU2525182C1 (ru) * 2013-02-28 2014-08-10 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России) Способ лечения больных хроническим простатитом с парциальным андрогенодефицитом
CN104161739B (zh) * 2014-08-15 2017-09-19 武汉人福药业有限责任公司 非那雄胺胶囊及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2227876A (en) * 1937-10-16 1941-01-07 Firm Of N V Organon Steroid derivatives with nuclear substituted nitrogen
US3285918A (en) * 1962-04-18 1966-11-15 Norman J Doorenbos 1', 4', 5', 6'-tetrahydropyrimidino[a-4, 3]-4-aza-5-cholestene
US3239417A (en) * 1962-12-07 1966-03-08 Smith Kline French Lab Methods and compositions for inhibiting sterol biosynthesis
US3264301A (en) * 1963-08-22 1966-08-02 Norman J Doorenbos Substituted-4-azasteroids
FR1465544A (fr) * 1965-11-29 1967-01-13 Roussel Uclaf Dérivés stéroïdes aromatiques substitués par un atome d'azote endocyclique et procédé de préparation
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4220775A (en) * 1979-03-15 1980-09-02 Merck & Co., Inc. Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors
US5049562A (en) * 1984-02-27 1991-09-17 Merck & Co., Inc. 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors
US4859681A (en) * 1984-02-27 1989-08-22 Merck & Co., Inc. 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
DE3888378T2 (de) * 1987-04-03 1994-09-29 Merck & Co Inc Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.
US4946688A (en) * 1988-07-05 1990-08-07 Fahim Mostafa S Intraprostatic injection of zinc ions for treatment of inflammatory conditions and benign and malignant tumors of the prostate
DK627289D0 (da) * 1989-12-12 1989-12-12 Per C Oden Anvendelse af bicyclononanderivater
US5175155A (en) * 1991-10-07 1992-12-29 Sterling Winthrop Inc. Win 49596-finasteride method of use and compositions
WO1993023039A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors
US5710275A (en) * 1992-05-20 1998-01-20 Merck & Co., Inc. 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives
US5693810A (en) * 1992-10-06 1997-12-02 Merck & Co., Inc. 17 β-carboxanilides of 4-aza-5α-androstan-3-ones as 5α-reductase inhibitors

Also Published As

Publication number Publication date
HU9501777D0 (en) 1995-08-28
EP0674521A4 (en) 1998-02-04
PT674521E (pt) 2001-10-31
ES2158887T3 (es) 2001-09-16
DE69330465D1 (de) 2001-08-23
EP0674521A1 (en) 1995-10-04
WO1994014452A1 (en) 1994-07-07
AU691164B2 (en) 1998-05-14
NO952427L (no) 1995-06-16
EP0674521B1 (en) 2001-07-18
NZ258435A (en) 1997-05-26
JPH08504813A (ja) 1996-05-28
CA2151239A1 (en) 1994-07-07
GR3036241T3 (en) 2001-10-31
AU5610594A (en) 1994-07-19
HUT73231A (en) 1996-07-29
CZ285379B6 (cs) 1999-07-14
NO308829B1 (no) 2000-11-06
DE69330465T2 (de) 2002-04-25
HU220064B (hu) 2001-10-28
US5629318A (en) 1997-05-13
FI953002A (sv) 1995-06-16
CZ157795A3 (en) 1995-11-15
DK0674521T3 (da) 2001-09-24
NO952427D0 (no) 1995-06-16
ATE203162T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
ATE307119T1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
DK0687268T3 (da) Spiroazacykliske derivater som substans P-antagonister
NO971538L (no) Purin- og guaninforbindelser som inhibitorer for PNP
FI970149A (sv) Användning av tiazol- och tiadiazolföreningar som D3-receptorligander
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
ES2117243T3 (es) Nuevos antioxidantes fenolicos liquidos.
ATE319680T1 (de) Substituierte 2-benzylamino-2-phenyl- acetamidverbindungen
FI953002A0 (sv) Förfarande för behandling av kronisk prostatainflammation med 17beta-N-monosubstituerade-karbamoyl-4-aza-5alfa-androst-1-en-3-oner
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
DE69307895D1 (de) Therapeutische verwendung von phosphoryl-l-serin-n-acyl-sphingosin
ATE191465T1 (de) Carbamoylcarbonsäureamide
DE69623767D1 (de) Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus
FI952855A0 (sv) Nya trizolokinazoliner, framställning och användning av dem
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
ATE206127T1 (de) Inhibitoren retroviraler proteasen
ES2173634T3 (es) Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.

Legal Events

Date Code Title Description
FD Application lapsed